Latest News about ASND
Recent news which mentions ASND
From Benzinga
From Benzinga
Why Is BioMarin Stock Trading Higher On Thursday?
February 20, 2025
From Benzinga
Here's How Much $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today
February 19, 2025
From Benzinga
From Benzinga
Earnings Scheduled For February 12, 2025
February 12, 2025
From Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
January 23, 2025
From Benzinga
This Coca-Cola Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
January 07, 2025
From Benzinga
Earnings Scheduled For November 14, 2024
November 14, 2024
From Benzinga
From Benzinga
Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug
November 04, 2024
From Benzinga
From Benzinga
From Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
October 08, 2024
From Benzinga
BioMarin Stands Firm on 2027 Revenue Target Amid Ascendis Competition, Goldman Sachs Analyst Remains Bullish
September 25, 2024
From Benzinga
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years
September 24, 2024
From Benzinga
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
From Benzinga
Novo Nordisk, Chewy And FedEx Are Among Top 10 Large Cap Losers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio?
September 22, 2024
From Benzinga
Despite Being First Mover, BioMarin's Voxzogo For Dwarfism To Face Pressure From Ascendis' Candidate In Near Term
September 16, 2024
From Benzinga
Crude Oil Surges Over 1%; Instil Bio Shares Plunge
September 16, 2024
From Benzinga
Ascendis Pharma's Rare Dwarfism Candidate Shows Promise In Trial, FDA Submission Expected Next Year
September 16, 2024
From Benzinga
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
September 16, 2024
From Benzinga
Ascendis Pharma Faces Challenges With Skytrofa And Yorvipath Pricing: Analysts Weigh In
September 04, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.